Epidemiology

Epidemiology conducts research on health and disease at the population level – infection epidemiology is concerned with contagious diseases. Their tools and methods are systematic queries, clinical examinations and laboratory diagnostic documentation for both healthy and afflicted individuals, as well as statistical analysis of the compiled data. Causes and risk factors for infections can thus be identified.

Infectious diseases epidemiology contributes to the development of preventive measures, early detection and therapy for diseases. Moreover, it examines the efficacy of such measures. Thus epidemiology ties in with scientific findings in basic research as well as medicine, and examines these processes at the population level.

Team

    Dr Jördis J. Ott

    Scientist

    +49 531 6181-3115

    Contact


    Publications

    2016

    Ott JJ, Horn J, Krause G, Mikolajczyk RT. Time trends of chronic HBV infection over prior decades – A global analysis. J Hepatol 2016, Aug 31. doi: 10.1016/j.jhep.2016.08.013. [Epub ahead of print]

    Klett-Tammen CJ, Krause G, Seefeld L, Ott JJ. Determinants of tetanus, pneumococcal and influenza vaccination in the elderly: a representative cross-sectional study on knowledge, attitude and practice (KAP). BMC Public Health 2016; 16:121; http://dx.doi.org/10.1186/s12889-016-2784-8

    Ott JJ, Horn J. Changing hepatitis B virus epidemiology in rural China. Correspondence. Lancet Infect Dis 2016; 16: 150; http://dx.doi.org/10.1016/S1473-3099(15)00545-9

    2015

    Schweitzer A, Horn J, Mikolajczyk R, Krause G, Ott JJ. Worldwide prevalence of chronic hepatitis B virus infection: Estimations based on a systematic review of data published between 1965 and 2013.The Lancet 2015; published online July 28, 2015; http://dx.doi.org/10.1016/S0140-6736(15)61412-X

    2014

    Rübsamen N, Castell S, Horn J, Karch A, Ott JJ, Raupach-Rosin H, Zoch B, Krause G, Mikolajczyk RT. Ebola risk perception in Germany, 2014. Emerg Infect Dis 2015, 21: 1012-8.

    2013

    Ott JJ, Wiersma ST. Single dose administration of inactivated hepatitis A vaccination in the context of hepatitis A vaccine recommendations. Int J Infect Dis 2013; 17:e939-44, doi: 10.1016/j.ijid.2013.04.012

    Ott JJ, Klein Breteler J, Tam JS, Hutubessy RC, Jit M, de Boer MR. Influenza vaccines in low and middle income countries: A systematic review of economic evaluations. Hum Vaccin Immunother 2013, 9: 1500-11

    Winkler V*, Ott JJ*, Cowan M, Becher H. Smoking prevalence and its impacts on lung cancer mortality in Sub-Saharan Africa: An epidemiological study. Prev Med 2013; 57: 634-40, doi: 10.1016/j.ypmed.2013.08.022 * equal contr.

    2012

    Ott JJ, Stevens GA, Wiersma ST. The risk of perinatal hepatitis B virus transmission: Hepatitis B e antigen prevalence estimates for all world regions. BMC Infect Dis 2012, 12: 131.

    Ott JJ, Irving G, Wiersma ST. Long-term protective effects of hepatitis A vaccines: A systematic review. Vaccine 2012, 31: 3-11.

    Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine 2012, 30: 2212-9.

    2011

    Ullrich A, Ott JJ, Vitoria M, Martin-Moreno JM, Atun R. Long-term care of AIDS and non-communicable diseases. Lancet 2011, 377: 639-40.

    2010

    Ott JJ, Ullrich A, Mascarenhas M, Stevens GA. Global cancer incidence and mortality caused by behavior and infection. J Public Health (Oxf). 2010, 33: 223-33.

    Winkler V, Ott JJ, Becher H. Reliability of coding causes of death with ICD-10 in Germany. Int J Public Health 2010, 55:43-8.

    Ott JJ, Paltiel AM, Winkler V, Becher H. Effects of duration of residence and differences between FSU-migrants in two countries. Health Place 2010, 16: 79-84. 

    2009

    Ott JJ, Ullrich A, Miller AB. The importance of early symptom recognition in the context of early detection and cancer survival. Eur J Cancer 2009, 45: 2743-8 

    Ott JJ, Paltiel AM, Becher H. Non-communicable disease mortality and life expectancy of migrants from the Former Soviet Union in Israel. A comparison between country of origin and host country. Bull World Health Organ 2009, 87:20-9.

    Winkler V, Ott JJ, Holleczek E, Stegmaier C, Becher H. Cancer profile of migrants from the Former Soviet Union in Germany: Incidence and mortality. Cancer Causes & Control 2009, 20: 1873-79.

    Ronellenfitsch U, Kyobutungi C, Ott JJ, Paltiel A, Razum O, Schwarzbach M, Winkler V, Becher H. Stomach cancer mortality in two large cohorts of migrants from the former Soviet Union to Israel and Germany: are there implications for prevention? Eur J Gastroenterol Hepatol  2009, 21: 409-16.

    Ott JJ. Fundamentals of cancer epidemiology. Bull World Health Organ 2009, 87: 644.

    2008

    Ott JJ, Paltiel AM, Winkler V, Becher H. Chronic disease mortality associated with infectious agents: A comparative cohort study of migrants from the Former Soviet Union in Israel and Germany. BMC Public Health 2008, 8:110.

    Ott JJ, Winkler V, Kyobutungi C, Laki J, Becher H. Effects of residential changes and time patterns on external cause mortality in migrants: Results of a German cohort study. Scand J Public Health 2008, 36: 524-31.

    2007

    Becher H, Razum O, Kyobutungi C, Laki J, Ott JJ, Ronellenfitsch U, Winkler V. Mortalität von Aussiedlern aus der ehemaligen Sowjetunion. Ergebnisse einer Kohortenstudie [German]. Dtsch Arztebl 2007, 104 (23):A-1655-1661.

     

    Conferences

    2015

    Ott JJ. Seroprevalence of HBV infection: Global variation in data and results. 15th International Symposium on Viral Hepatitis and Liver Disease (ISVHLD), 2015, Germany. [Invited oral presentation].

    Schweitzer A, Horn J, Mikolajczyk M, Krause K, Ott JJ. The global prevalence of chronic HBV infection: a systematic review and meta-analyses on 48 years of published data. 15th International Symposium on Viral Hepatitis and Liver Disease (ISVHLD) 2015, Germany. [Poster]

    Bohm K, Krause G, Ott JJ, Sievers C. Multiplex serology for Hepatitis A and Hepatitis E Virus Infections. 15th International Symposium on Viral Hepatitis and Liver Disease (ISVHLD) 2015, Germany. [Poster]

    Klett-Tammen CJ, Krause G, Seefeld L, Castell S, Ott JJ. Pneumokokkenimpfung im höheren Lebensalter – wie Wissen, Einstellungen und Verhaltensweisen auf Nutzer- und Anbieterseite die Inanspruchnahme der Impfung bedingen. 4. Nationale Impfkonferenz, 2015; Germany. Abstract P03-06. 2015; 32-33. [Poster]

    Rübsamen N, Castell S, Horn J, Karch A, Ott JJ, Raupach-Rosin H, Zoch B, Krause G, Mikolajczyk RT. Risk perception during the 2014 Ebola virus disease epidemic: results of a German survey in Lower Saxony. European Congress of Epidemiology 2015, Netherlands. [Poster]

    Klett-Tammen CJ, Seefeld L, Krause G, Ott JJ. Generation of knowledge-, attitude- and practice- scores as predictors for vaccination in the elderly. European Congress of Epidemiology 2015, Netherlands. [Poster]

    Ott JJ. Efforts to estimate HBV prevalence and future trends.  50th International Liver Congress, 2015, Austria. [Invited oral presentation].

    2014

    Klett-Tammen CJ, Ott JJ, Castell S, Seefeld L, von Lengerke T, Krause G. Infectious diseases prevention and vaccination in the elderly Joint Congress of the German Society for Medical Psychology and the German Society for Medical Sociology (DGMP-DGMS), 2014. ISBN: 978-3-89967-991-5. [Oral presentation]

    2012

    Winkler V, Ott JJ, Cowan M, Becher H. Tobacco smoking prevalence in Sub-Saharan Africa implies higher lung cancer mortality estimates. 15th World Conference on Tobacco or Health (WCTOH). 2012, Singapore.

    2011

    Winkler V, Ott JJ, Cowan M, Becher H. How to estimate lung cancer mortality in low income countries? The example of Sub-Saharan Africa. German Epidemiology Association Conference 2011, Germany.

    2010

    Ullrich A, Ott JJ. Cancer control plans in Europe. Session: Overcoming disparities in cancer control in Europe. 35th EMSO Congress 2010, Italy.

    Ullrich A, Ott JJ. The need for consistent data for cancer prevention. Indicators for cancer control. World Cancer Congress 2010, China.

    2009

    Ott JJ. WHO strategies in cancer control. 2ème Journée Francophone de Lutte Contre le Cancer. 2009, France.

    2008

    Ronellenfitsch U, Kyobutungi C, Ott JJ, Paltiel A, Razum O, Schwarzbach M, Winkler V, Becher H. Stomach cancer mortality in two cohorts of migrants from a high-risk area: are there implications for prevention and screening? Poster. German Epidemiology Association Conference 2008, Germany

    2007

    Ott JJ, Paltiel AM, Becher H. Mortality patterns of Former Soviet Union immigrants in Israel 1990-2003. 15th Conference of the European Public Health Association (EUPHA), 2007, Finland. Eur J Public Health 2007, 17,S2: 65

    Ott JJ, Becher H, ICMH study group. Diabetes and Migration. Status report. Satellite meeting at the European Conference “Health and Migration in the EU- Better Health for All in an Inclusive Society”, 2007, Portugal.

    2006

    Becher H, Kyobutungi C, Laki J, Ott JJ, Razum O, Ronellenfitsch U, Winkler V. Mortality in a cohort of migrants from the FSU to Germany. International Epidemiology Association Congress 2006, Netherlands.  Eur J Epidemiol, 2006, 21, Suppl. 49

    Becher H, Kyobutungi C, Laki J, Ott JJ, Razum O, Ronellenfitsch U, Winkler V. External cause mortality among a cohort of migrants with high residential mobility. German Epidemiology Association Conference 2006, Germany.

     

     

Leader

News

  • SORMAS - the future of epidemic surveillance
    Epidemiologists and IT experts from Germany and Nigeria have jointly developed an innovative app to help fight epidemics like ebola or cholera - the Surveillance Outbreak Response Management and Analysis System (SORMAS). This video explains why a tool like SORMAS is urgently needed and introduces the unique approach that makes SORMAS so powerful.

Audio Podcast

  • Staphylococcus aureus – ein Leben in der Nase
    2000 zufällig ausgewählte Braunschweiger Bürger haben in diesem Juni Post vom HZI erhalten – mit der Bitte, an einer Studie über die Verbreitung von Staphylococcus aureus teilzunehmen. Varianten des Bakteriums sind unter dem Kürzel MRSA als Krankenhauskeime zu trauriger Berühmtheit gelangt. Unsere Wissenschaftler wollen nun erforschen, wie viele Gesunde – außerhalb von Krankenhäusern – mit diesem Keim Leben. Und sie suchen nach Risikofaktoren, die Staphylococcus aureus die Besiedlung des Menschen erleichtern. Begleiten Sie Frank Pessler und Jaishri Mehraj ein Stück in die Welt der Epidemiologie...
  • Proben und Fragebögen für die Infektionsforschung - Die Nationale Kohorte
    Diabetes mellitus, Krebs, Arterienverkalkung und diverse Infektionen sind Volkskrankheiten, über die wir viel zu wenig wissen. Mit der Nationalen Kohorte wollen Wissenschaftler diesen Krankheiten auf den Grund gehen und neue Strategien gegen sie entwickeln. Frank Pessler und Manas Akmatov nehmen die Infektionen ins Visier. Lassen Sie sich erklären, wie ihnen 225.000 Menschen dabei helfen sollen…